Related Experiment Videos
Ultrastructure of exogenous surfactants using cryogenic scanning electron microscopy
1Cardiovascular Research Institute, University of California, San Francisco 94118-1245, USA. rban@itsa.ucsf.edu
Journal of Biomaterials Applications
|March 23, 2001
Summary
This study compared the ultrastructure of three respiratory distress syndrome surfactants. ALEC exhibited the most organized liposomal structure, suggesting potential for improved artificial surfactant development.
Area of Science:
- Biomaterials Science
- Pulmonary Medicine
- Microscopy
Background:
- Exogenous surfactants are crucial for treating Respiratory Distress Syndrome (RDS), reducing mortality rates.
- Commercial surfactants differ significantly in composition and biophysical properties.
- Understanding surfactant ultrastructure is key to developing improved treatments.
Purpose of the Study:
- To investigate and compare the liposomal formation and ultrastructure of three exogenous surfactants: Survanta, ALEC, and Exosurf Neonatal.
- To correlate ultrastructural findings with surfactant composition and potential function.
Main Methods:
- Cryogenic scanning electron microscopy was employed to visualize the ultrastructure of Survanta, ALEC, and Exosurf Neonatal.
- Detailed analysis of liposomal organization and membrane structures was performed.
Main Results:
- ALEC demonstrated the most pronounced and regular closed liposomal organization with an "onion-ring-like" internal bilayer structure.
- Survanta formed open membranous structures with wavy, ribbon-like membranes, potentially due to interactions with surfactant proteins.
- Exosurf Neonatal showed more obvious liposomal organization than Survanta but less than ALEC.
Conclusions:
- ALEC exhibits superior liposomal organization compared to Survanta and Exosurf Neonatal.
- The presence of proteins in Survanta may contribute to its unique membranous structures and potential for enhanced spreading.
- Further research into biomaterial ultrastructure could lead to improved artificial, protein-free surfactants with enhanced lung surface activity.